STROMUSC High Quality GW501516(Cardarine)10mg For Bodybuilding CAS:317318-70-0
The pursuit of an optimized physique often leads bodybuilders and performance enthusiasts to explore compounds beyond traditional anabolic steroids. Among these, GW501516, ubiquitously dubbed "Cardarine," occupies a unique, controversial, and medically significant niche. This analysis provides a detailed, original examination of its role, moving beyond repetitive summaries to deliver a fresh perspective on its mechanisms, paradoxical applications, and critical risks.
What is GW501516?
GW501516 is not a SARM (Selective Androgen Receptor Modulator), a common misconception that dangerously misclassifies it. It is a PPARδ (Peroxisome Proliferator-Activated Receptor Delta) agonist, originally synthesized in the 1990s by GlaxoSmithKline and Ligand Pharmaceuticals. Its intended purpose was therapeutic: to treat metabolic diseases like dyslipidemia, obesity, and type 2 diabetes by altering how the body processes fats and sugars.
Its journey was halted in early-stage clinical trials when toxicological studies revealed a rapid induction of cancers in multiple organs (liver, stomach, tongue, skin, testes, ovaries, uterus) in rodents, at all doses tested. Consequently, it was never approved for human medical use. Its presence in the bodybuilding and endurance worlds is entirely off-label and sourced from the research chemical market, where "10mg tablets" are a common, unregulated dosage form.
Core Features and Mechanism: The Engine Room
The unique features of Cardarine stem from its PPARδ activation, which distinguishes it from all other performance-enhancing compounds:
●Metabolic Reprogramming: It acts as a transcriptional regulator, turning on genes that govern lipid metabolism and mitochondrial biogenesis. Essentially, it reprograms muscles to preferentially use fatty acids for fuel, sparing glycogen.
●Non-Hormonal Action: It does not bind to androgen, estrogen, or progesterone receptors. Its effects are metabolic and endurance-based, not anabolic (muscle-building) or androgenic.
●Cellular Efficiency Enhancer: By upregulating the expression of proteins involved in mitochondrial function (like CPT-1 and PGC-1α), it increases the number and efficiency of mitochondria-the cellular power plants. This leads to a measurable shift in muscle fiber characteristics, enhancing oxidative (Type I) endurance capacity.
Paradoxical Applications in Bodybuilding
Given its non-anabolic nature, its use in bodybuilding is strategic and adjunctive, addressing specific challenges:
●The Cutting Phase Paradox: During a calorie deficit, athletes seek to preserve muscle while shedding fat. Cardarine's purported ability to enhance fat oxidation and dramatically increase work capacity allows for more intense, voluminous fasted or depleted-state cardio sessions. This can theoretically create a greater daily energy deficit without the catabolic stress typically associated with excessive cardio.
●Performance Bridge: It is used to break through endurance plateaus in training. By allowing for more work (more sets, reps, or cardio minutes) with less perceived exertion and faster recovery between sets, it can indirectly stimulate muscle growth through increased training stimulus and improved nutrient partitioning.
●Glycogen Sparing & Nutrient Partitioning: The shift to fat as a primary fuel source may help preserve intramuscular glycogen. This can lead to fuller-looking muscles even in a deficit and provide sustained energy for weight training sessions after cardio.
Perceived Benefits: A Nuanced View
The benefits attributed to it are primarily extensions of its mechanistic features. A novel interpretation frames them as enhancements of metabolic resilience:
●Dramatically Increased Endurance: The most consistently reported effect. Users describe a "second wind" and an ability to sustain high-output activity 50-100% longer. This is not a stimulant effect; it's a genuine improvement in aerobic capacity.
●Accelerated Fat Loss: By promoting lipid oxidation, it may expedite the mobilization and burning of stored adipose tissue, particularly when paired with cardiovascular exercise.
●Improved Recovery and Reduced Muscle Soreness: Enhanced mitochondrial efficiency and reduced inflammation (via PPARδ activation) may decrease DOMS (Delayed Onset Muscle Soreness) and improve inter-session recovery, not through muscular repair but via systemic metabolic and anti-inflammatory effects.
●Enhanced Blood Lipid Profiles: It can significantly improve cholesterol ratios (increasing HDL, decreasing LDL and triglycerides). While a health-positive marker, this is ironic given the compound's overarching cancer risk.
Dosage, Cycle, and Half-Life: A Framework of Caution
It is imperative to state that no safe dosage for human use has been established. All protocols are derived from anecdotal, non-clinical use.
●Dosage: The common 10mg tablet reflects the typical daily dose. Anecdotal ranges run from 10-20mg per day, often taken once daily due to the long half-life. Starting at the lowest possible dose (e.g., 5mg) is a frequently ignored but prudent approach.
●Cycle Length: Given the rodent carcinogenicity data where cancers appeared with sustained exposure, short-term use is a non-negotiable risk-mitigation strategy. Cycles are typically kept between 6-8 weeks, followed by a minimum equal period off. Some protocols advocate for even shorter 4-week bursts.
●Half-Life: GW501516 has a very long half-life of approximately 16-24 hours. This allows for once-daily dosing and means the compound accumulates in the system over time. Its effects can linger for days after cessation. This pharmacokinetic property is critical; sustained receptor activation is a key factor in the pathological pathways observed in toxicology studies.
PTC (Post-Therapy Care): Beyond the Pill
A novel and crucial component often omitted is the concept of Metabolic and Health Surveillance PTC. Since Cardarine is not hormonally suppressive, classic PCT (Post-Cycle Therapy) with SERMs is irrelevant. Instead, the focus must shift:
●Health Biomarker Monitoring: Post-cycle, comprehensive blood work-including a full lipid panel, liver enzymes, and inflammatory markers-is essential to assess the compound's impact and track a return to baseline.
●Aggressive Antioxidant and Detoxification Support: Given the potential oxidative and proliferative stresses, a robust post-cycle nutrition plan rich in cruciferous vegetables (sulforaphane), potent antioxidants (NAC, Vitamin E, Selenium), and compounds that support cellular health (like Omega-3s) should be emphasized.
●Performance Recalibration: Athletes must mentally and physically adjust training volumes, as the significant endurance boost will vanish. Continuing pre-cycle workloads may lead to overtraining and injury.
The Inescapable Risk Profile: A Necessary Coda
No discussion is complete without foregrounding the unequivocal, black-box warning: GW501516 is a confirmed multi-organ carcinogen in animal models. The toxicology studies were compelling enough to terminate all human development. The dose-response relationship in rodents suggests the risk is mechanism-based (PPARδ-driven), not a toxic byproduct.
The argument that "rodent studies don't always translate to humans" is a perilous gamble when the stakes are metastatic cancer. The latency period for such pathologies could be years, making anecdotal reports of "safety" over a few cycles meaningless. Furthermore, the unregulated nature of "10mg tablets" poses additional risks of mislabeling, contamination, and inconsistent purity.
Clinical Data
|
Brand |
STROMUSC |
|
Trade names |
GW501516,Cardarine,Endurobol,GSK-516 |
|
CAS |
317318-70-0 |
|
Molar mass |
453.49 |
|
MF |
C21H18F3NO3S2 |
|
Purity |
Above 98% |
|
Apprarance |
10mg*100 |
Any needs, please contact us
Email: Jasonraws106@gmail.com
WhatsApp: +86-15572565525
Telegram: +86-15871669785
Conclusion: A High-Stakes Metabolic Tool
In the final analysis, GW501516 (Cardarine) represents a profound paradox: a compound capable of producing undeniable, potent enhancements in metabolic performance and body composition, yet shadowed by a severe and validated oncological risk profile. Its application in bodybuilding is a calculated, off-label experiment in metabolic manipulation, offering benefits that are functional rather than structural. For the informed individual, the decision hinges on a dire risk-reward calculus, where the potential short-term physique benefits are weighed against a long-term, potentially devastating health outcome. Any consideration must begin and end with the unequivocal understanding that this is a research chemical with no safe human dosage established and a foreboding toxicological legacy. Responsible discourse must prioritize this warning above all discussions of its performance attributes.
Hot Tags: stromusc high quality gw501516(cardarine)10mg for bodybuilding cas:317318-70-0, China stromusc high quality gw501516(cardarine)10mg for bodybuilding cas:317318-70-0 manufacturers, suppliers, factory, RAD140 increase lean muscle mass, GW0742 Hormone and Metabolic Regulators, GW501516, AC-262, LGD3303 Selective androgen receptor modulator, LGD4033
